Compare Novartis AG (NVS) vs Phillips 66 (PSX) Price & Performance

Novartis AGTrade

Phillips 66Trade

Price performance (Past 24H)

Key statistics

Novartis AG vs Phillips 66 — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Phillips 66 trades at $212.27 (market cap $83.72B). The key difference: Novartis AG is far larger — about 3.5× Phillips 66's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.

	NVS	PSX
Market Cap	$290.25B	$83.72B
Sector	Health	Energy
52-Week High	$168.62	$208.80
52-Week Low	$113.50	$118.37
Enterprise Value	$330.27B	$105.69B
Dividend Yield	3.17%	2.43%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVS

Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.Gordon Thompson · 23 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral FDA approves Fabhalta as first drug to significantly slow kidney decline in IgAN patientsNovartis · 4 days agoBullish View details →

PSX

View details →

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

About Phillips 66

Phillips 66 is an independent refiner with 12 refineries that have a total crude throughput capacity of 2.0 million barrels per day, or mmb/d, after converting its 255 mb/d Alliance refinery to a terminal. The midstream segment comprises extensive transportation and NGL processing assets. It also includes its DCP Midstream joint venture, which holds 45 natural gas processing facilities, 11 NGL fractionation plants, and a natural gas pipeline system with 58,000 miles of pipeline. Its CPChem chemical joint venture operates facilities in the United States and the Middle East and primarily produces olefins and polyolefins.